INNO-LiPA® HLA-C

Detects all known alleles of HLA-C with one amplification and one strip

INNO-LiPA HLA-C is a line probe assay for the molecular typing of human leukocyte antigen (HLA) C alleles at allele group level (Cw*01 – Cw*18).

Please note that this product now only is available for sale in Spain and Italy. Contact us for more details.

Contact sales for information
CE marked
INNO-LiPA HLA-C

Product number 80342

20 Tests
INNO-LiPA HLA-C Amplification

Product number 80343

20 Tests
Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

  • Contact sales for information
  • Details
  • Conditions of sale
  • Citations
  • Documentation
  • Insights
  • Product inquiry
  • Related products

  • Details

    Features & Benefits

    More informative than serology

    • INNO-LiPA HLA-C yields more information on genetic variation
    • New alleles mainly appear as new probe patterns, not blanks
    • Null alleles can be detected

    Convenient

    • Reagents are synthesized and are therefore not limited in quantity
    • Reagents are standardized to show minimal batch-to-batch differences
    • INNO-LiPA HLA-C utilizes DNA samples that are easy to transport
    • Cell viability or surface expression is not important
    • One strip replaces multiple testing

    Rapid

    • INNO-LiPA HLA-C can be used for large batch analysis
    • One technician – one to one hundred samples – one working day

    Simple

    • The LiPA technique is easy to perform
    • Automation is possible using TENDIGO™ and Auto-LiPA™ 48
    • Objective interpretation of data with LiRAS® for LiPA HLA software

  • Conditions of sale

    To read the end user conditions of sale for this product please visit our Resource center.

  • Citations

    The BIOZ badges associated with Fujirebio products include peer-reviewed citations derived from scientific studies using Fujirebio products. Please note that the peer-reviewed citations do not reflect the regulatory status of Fujirebio products. Users should refer to the specific product documentation and any (clinical) claims made therein in order to ensure compliant use. For each country or geographic region, users must verify the related regulatory status of the Fujirebio product.

  • Insights

  • Product inquiry

    CAPTCHA

    The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

    For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

    If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.